Watchlist Price Alert

BioRestorative Therapies ... (BRTX)

NASDAQ: BRTX · Real-Time Price · USD

1.72

0.10 (6.17%)

At close: Jun 17, 2025, 3:59 PM

1.71

-0.58%

After-hours: Jun 17, 2025, 07:22 PM EDT

6.17% (1D)

Bid	1.68
Market Cap	12.91M
Revenue (ttm)	391K
Net Income (ttm)	-12.1M
EPS (ttm)	-1.47
PE Ratio (ttm)	-1.17
Forward PE	-1.56
Analyst	Strong Buy

Ask	1.72
Volume	378,680
Avg. Volume (20D)	94,958
Open	1.66
Previous Close	1.62
Day's Range	1.65 - 1.79
52-Week Range	1.21 - 2.55
Beta	0.36

About BRTX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BRTX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BRTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

4 days ago

-16%

BioRestorative Therapies shares are trading lower.... Unlock content with Pro Subscription

News

1 month ago · seekingalpha.com

BioRestorative Therapies, Inc. (BRTX) Q1 2025 Earnings Call Transcript

BioRestorative Therapies, Inc. (NASDAQ:BRTX ) Q1 2025 Earnings Call May 14, 2025 4:30 PM ET Company Participants Stephen Kilmer - Investor Relations Lance Alstodt - Chairman and Chief Executive Office...

1 month ago · zacks.com

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Lags Revenue Estimates

Biorestorative Therapies, Inc. (BRTX) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.53 per share a year ago.

2 months ago · seekingalpha.com

BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call Transcript

BioRestorative Therapies, Inc. (NASDAQ:BRTX ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Stephen Kilmer – Investor Relations Lance Alstodt – Chairman and Chief Exe...